Radioembolization Versus Chemoembolization (DEBDOX) for the Treatment of Unresectable Hepatocellular Carcinoma: A Propensity Matched Study

OLAGUOKE AKINWANDE; PREJESH PHILIPS; CHARLES SCOGGINS; ROBERT C.G. MARTIN

Research ArticleClinical Studies

Radioembolization Versus Chemoembolization (DEBDOX) for the Treatment of Unresectable Hepatocellular Carcinoma: A Propensity Matched Study

OLAGUOKE AKINWANDE, PREJESH PHILIPS, CHARLES SCOGGINS and ROBERT C.G. MARTIN

Anticancer Research January 2016, 36 (1) 239-246;

OLAGUOKE AKINWANDE

1Department of Radiology, Division of Interventional Radiology, Johns Hopkins University, Baltimore, MD, U.S.A.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

PREJESH PHILIPS

2Department of Surgical Oncology, University of Louisville, Louisville, KY, U.S.A.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

CHARLES SCOGGINS

2Department of Surgical Oncology, University of Louisville, Louisville, KY, U.S.A.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

ROBERT C.G. MARTIN

2Department of Surgical Oncology, University of Louisville, Louisville, KY, U.S.A.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: Robert.Martin{at}louisville.edu

Article
Figures & Data
Info & Metrics
PDF

Article Figures & Data

Figures

Tables

Download figure
Open in new tab
Download powerpoint
Figure 1.
⁹⁰Y versus DEBDOX overall survival for the pooled cohort (a). ⁹⁰Y versus DEBDOX progression-free survival for the pooled cohort (b).
Download figure
Open in new tab
Download powerpoint
Figure 2.
⁹⁰Y versus DEBDOX overall survival for the matched cohort (a). ⁹⁰Y versus DEBDOX progression-free survival for the matched cohort (b).
Download figure
Open in new tab
Download powerpoint
Figure 3.
⁹⁰Y versus DEBDOX overall survival for the portal vein thrombosis sub-group.

Tables

Figures

PreviousNext

In this issue

Anticancer Research

Vol. 36, Issue 1

January 2016

Table of Contents
Table of Contents (PDF)
Index by author
Back Matter (PDF)
Ed Board (PDF)
Front Matter (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Radioembolization Versus Chemoembolization (DEBDOX) for the Treatment of Unresectable Hepatocellular Carcinoma: A Propensity Matched Study

Message Subject (Your Name) has sent you a message from Anticancer Research

Message Body (Your Name) thought you would like to see the Anticancer Research web site.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Math question * 2 + 0 =

Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

Citation Tools

Radioembolization Versus Chemoembolization (DEBDOX) for the Treatment of Unresectable Hepatocellular Carcinoma: A Propensity Matched Study

OLAGUOKE AKINWANDE, PREJESH PHILIPS, CHARLES SCOGGINS, ROBERT C.G. MARTIN

Anticancer Research Jan 2016, 36 (1) 239-246;

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Reprints and Permissions

Radioembolization Versus Chemoembolization (DEBDOX) for the Treatment of Unresectable Hepatocellular Carcinoma: A Propensity Matched Study

OLAGUOKE AKINWANDE, PREJESH PHILIPS, CHARLES SCOGGINS, ROBERT C.G. MARTIN

Anticancer Research Jan 2016, 36 (1) 239-246;

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Jump to section

Article
Figures & Data
Info & Metrics
PDF

Cited By...

Liver-dominant Breast Cancer Metastasis: A Comparative Outcomes Study of Chemoembolization Versus Radioembolization
Survival Following Palliative External-beam Radiotherapy of Locally Advanced and Metastatic Liver Cancer

Google Scholar

Keywords

efficacy
toxicity
DEBTACE
RECIST
Ytrrium-90
DEBDOX
radioembolization
chemoembolization
Hepatocellular carcinoma

Main menu

User menu

Search

Radioembolization Versus Chemoembolization (DEBDOX) for the Treatment of Unresectable Hepatocellular Carcinoma: A Propensity Matched Study

Article Figures & Data

Figures

Tables

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Keywords